Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002553)
School of Medicine, Duke University
Received: 15 November 2020
Accepted: 19 April 2021
First Online: 1 May 2021
: Informed written consent was obtained from all participants upon their inclusion in the study. The study was approved by the DUHS IRB in Durham, North Carolina on 1/15/2019 (Reference ID: 294616), in accordance with all applicable Health Insurance Portability and Accountability Act ("HIPAA") regulations.
: Not applicable.
: VCN was partially supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002553. This manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All other authors have no competing interests. WAJ is a consultant and has received royalties for hip and knee products from Depuy Synthes, A Johnson & Johnson Company for work not related to this submitted article. WAJ has stock and/or stock options in Biomech Holdings LLC, a company not related to this research. KDA, SZG, JPG have received funding from the National Institutes of Health and Patient Centered Outcomes Research Institute for research not directly related to the submitted article. JPG has received funding from the Department of Veterans Affairs for research not directly related to the submitted article. KDA has received funding from the Department of Defense and the Department of Veterans Affairs for research not directly related to the submitted article. SZG has received payments from Rehab Essentials, Inc. that is not related to the submitted article. CLG, SZG, KDA, JPG have no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.